U.S. markets open in 34 minutes
  • S&P Futures

    3,817.75
    +1.00 (+0.03%)
     
  • Dow Futures

    31,291.00
    +55.00 (+0.18%)
     
  • Nasdaq Futures

    12,685.75
    +4.00 (+0.03%)
     
  • Russell 2000 Futures

    2,205.50
    -0.30 (-0.01%)
     
  • Crude Oil

    62.34
    +1.06 (+1.73%)
     
  • Gold

    1,711.80
    -4.00 (-0.23%)
     
  • Silver

    26.10
    -0.29 (-1.09%)
     
  • EUR/USD

    1.2039
    -0.0028 (-0.23%)
     
  • 10-Yr Bond

    1.4740
    +0.0040 (+0.27%)
     
  • Vix

    26.08
    +1.98 (+8.22%)
     
  • GBP/USD

    1.3967
    +0.0014 (+0.10%)
     
  • USD/JPY

    107.4560
    +0.4540 (+0.42%)
     
  • BTC-USD

    49,586.52
    -2,716.00 (-5.19%)
     
  • CMC Crypto 200

    993.82
    +6.61 (+0.67%)
     
  • FTSE 100

    6,650.07
    -25.40 (-0.38%)
     
  • Nikkei 225

    28,930.11
    -628.99 (-2.13%)
     

Surging Earnings Estimates Signal Upside for InMode (INMD) Stock

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

InMode (INMD) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.

The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this maker of cosmetic surgery devices, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For InMode, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

The company is expected to earn $0.61 per share for the current quarter, which represents a year-over-year change of +32.61%.

Over the last 30 days, the Zacks Consensus Estimate for InMode has increased 34.15% because one estimate has moved higher compared to no negative revisions.

Current-Year Estimate Revisions

For the full year, the company is expected to earn $1.78 per share, representing a year-over-year change of +9.2%.

There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, one estimate has moved up for InMode versus no negative revisions. This has pushed the consensus estimate 42.31% higher.

Favorable Zacks Rank

Thanks to promising estimate revisions, InMode currently carries a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

While strong estimate revisions for InMode have attracted decent investments and pushed the stock 17.6% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
InMode Ltd. (INMD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.